<?xml version="1.0" encoding="UTF-8"?>
<p>As discussed earlier, besides decreasing the serum levels of OVA-specific IgE, shikonin (
 <bold>1</bold>) was also observed to significantly decreased (
 <italic>p</italic> &lt; 0.05) the serum levels of IL-4 and significantly increased (
 <italic>p</italic> &lt; 0.05) the serum IFN-γ level (
 <xref rid="B106" ref-type="bibr">Wang et al., 2017</xref>). Previous study has reported that increasing the IFN-γ level and reducing the IL-4 level in the blood could alleviate the pathological lesion of AR in rats (
 <xref rid="B64" ref-type="bibr">Li et al., 1996</xref>). These findings indicated that the mechanism of shikonin attenuated AR may also involved reducing the level of IL-4 and increasing the level of IFN-γ in the body (
 <xref rid="B106" ref-type="bibr">Wang et al., 2017</xref>).
</p>
